These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 329809)

  • 1. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
    Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of the medium term use of verapamil and perhexiline in the treatment of chronic coronary insufficiency. Clinical and cycloergometric evaluation].
    Candau LA; Padilha JC; Tasca R; de Patta M; Weiskopf JS; Scherr C
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():51-62. PubMed ID: 678165
    [No Abstract]   [Full Text] [Related]  

  • 5. [Initial experience. Comparative study of verapamil and nifedipine in the treatment of coronary insufficiency. Evaluation by a cycloergometric test].
    Figueira RH; Guimarães F; Wagner M; Bozza AE; Dohmann HJ
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():39-43. PubMed ID: 354612
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of drugs upon exercise tests in coronary insuffiency.
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():79-81. PubMed ID: 329813
    [No Abstract]   [Full Text] [Related]  

  • 7. [Verapamil in the treatment of angina pectoris. Double-blind study with clinical-cycloergometric correlation].
    Maranhão MF; Lopes M; Toledo MT; Rojas RI; Michelotto PV; Michelotto PV; Lacerda FS; Furlan L; Cunha GP; Oliveira PF
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():95-9. PubMed ID: 329814
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of verapamil and fendiline in the treatment of chronic coronary insufficiency. Clinical and ergometric evaluation].
    Candau LA; Pereira LS; Lavall MA; Carvalho CR
    Arq Bras Cardiol; 1982 Aug; 39(2):135-8. PubMed ID: 6763518
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cycloergometric evaluation of propatylnitrate in chronic coronary insufficiency].
    Armaganijan D; Batlouni M; Ghorayeb N; Dioguardi GS; Ogawa C
    Arq Bras Cardiol; 1980 Jan; 34(1):73-7. PubMed ID: 6996650
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cross double-blind study with verapamil x placebo in ischemic heart disease with an ergometric test].
    Ribeiro JM; Sadi J; Barros FA
    Arq Bras Cardiol; 1984 Aug; 43(2):139-42. PubMed ID: 6398044
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cycloergometric evaluation of fendiline in chronic coronary insufficiency].
    Armaganijan D; Batlouni M; de Araújo JR
    Arq Bras Cardiol; 1979 Sep; 33(3):225-8. PubMed ID: 396912
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antia-angina effect of verapamil through the clinical and ergometric evaluation].
    Castro I; Pereira FA; Rodrigues R
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():75-7. PubMed ID: 329812
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of verapamil in the treatment of ventricular extrasystole in chronic Chagas' heart disease].
    Vichi FL; Nobre F; Evora P; Ribeiro PJ; Papa MV
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():101-6. PubMed ID: 407891
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of verapamil as a hypotensive agent - analysis of the arterial pressure curve in the cycloergometric test].
    Candau LA; Tasca R; Carvalho DM; Scherr C
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():18-23. PubMed ID: 7325859
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and cycloergometric evaluation of verapamil in the therapeutic of angina pectoris].
    Albuquerque DC; Schlesinger P; Benchimol CB; Albanesi FM; Benchimol AB
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():65-70. PubMed ID: 329810
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assessment of therapeutic effects of Verapamil by means of an exercise test].
    Goch JH; Rec A; Bala T
    Pol Tyg Lek; 1975 Sep; 30(36):1497-8. PubMed ID: 1161614
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the effect of verapamil on the tolerance for exertion in coronary patients].
    Miraglia G; Stritoni P; Egloff C; Scattolin G; Contessotto F; Passarin N; Dalla Volta S
    Boll Soc Ital Cardiol; 1979; 24(5):583-9. PubMed ID: 553643
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ergometric evaluation of the therapeutic effect of prolonged oral administration of delayed-action verapamil on 20 patients with stable effort angina].
    Martiny W; Bottone W; Matta F; Cerrone G; Minelli M; Angelino PF
    Minerva Cardioangiol; 1978 Dec; 26(12):811-8. PubMed ID: 368679
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK; Zaĭtseva VI
    Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrocardiographic and hemodynamic disorders induced by verapamil: experimental study].
    Belardinelli L; Sant'Anna JR; Mattos E; Wagner EM; Lucchese FA
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():31-6. PubMed ID: 329806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.